SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-21-001051
Filing Date
2021-06-16
Accepted
2021-06-16 16:09:18
Documents
7
Period of Report
2021-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K e2853_8-k.htm 8-K 28794
2 EX-5 e2853_ex5-1.htm EX-5 11022
3 EX-10 e2853_ex10-1.htm EX-10 53294
4 EX-10 e2853_ex10-2.htm EX-10 214071
5 EX-99 e2853_ex99-1.htm EX-99 7823
6 GRAPHIC img_002.jpg GRAPHIC 7901
7 GRAPHIC img001.jpg GRAPHIC 19462
  Complete submission text file 0001731122-21-001051.txt   354351
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 211021600
SIC: 2834 Pharmaceutical Preparations